We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HNI:NYSEHNI Corporation Analysis

Data as of 2026-04-08 - not real-time

$32.32

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

HNI is trading at $32.32, well below its DCF fair value of $61.19, implying more than 120% upside. Technical indicators are bearish: the price sits under the 20‑day (35.94), 50‑day (43.09) and 200‑day (44.52) SMAs, RSI is at 24.6, and the MACD histogram is negative, while 30‑day volatility spikes above 40%. Volume is decreasing, and the market sentiment is “Extreme Greed,” suggesting a potential disconnect between price and fundamentals. The dividend yield looks attractive at 4.21% but the payout ratio exceeds 120%, raising concerns about sustainability.
The recent acquisition of Steelcase creates a larger, more diversified workplace furnishings platform, offering significant synergy potential and a path to higher margins. Revenue growth of 38.3% and a forward EPS estimate of $4.83 (forward PE ~6.7) point to strong earnings expansion. Analysts rate the stock as a “strong buy” with a mean target of $72, reinforcing the undervaluation thesis. While short‑term technical pressure remains, the strategic transformation and valuation gap support a bullish stance for medium to long horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical position (price below all SMAs, low RSI)
  • High near‑term volatility and decreasing volume
  • Integration risk from the Steelcase acquisition

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Substantial valuation gap to DCF fair value
  • Forward earnings expansion and low forward PE
  • Synergy upside from the Steelcase merger

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic scale and diversified product portfolio
  • Sustained cash flow generation despite high debt
  • Long‑term earnings upside supported by strong revenue growth

Key Metrics & Analysis

Financial Health

Revenue Growth38.30%
Profit Margin1.91%
P/E Ratio29.1
ROE4.05%
ROA4.47%
Debt/Equity86.82
P/B Ratio1.3
Op. Cash Flow$276.3M
Free Cash Flow$156.8M

Technical Analysis

TrendBearish
RSI24.6
Support$31.41
Resistance$41.53
MA 20$35.94
MA 50$43.09
MA 200$44.52
MACDBearish
VolumeDecreasing
Fear & Greed Index84.77

Valuation

Fair Value$61.19
Target Price$72.00
Upside/Downside122.77%
GradeUndervalued
TypeGrowth
Dividend Yield4.21%

Risk Assessment

Beta0.83
Volatility41.01%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.